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A B S T R A C T
Purpose: To investigate the value of intraoperative MR imaging (iopMRI) combined with neuronaviga-
tion to avoid intraoperative underestimation of the resection amount during surgery of lesional temporal
lobe epilepsy (LTLE) patients.
Methods: We retrospectively investigated 88 patients (40 female, 48 male, mean age 37.2 yrs, from 12 to
69 yrs, 41 left sided lesions) with LTLE operated at our department, including 40.9% gangliogliomas (GG),
26.1% cavernomas (CM), 10.2% dysembryoplastic neuroepithelial tumours (DNT) and 11.4% focal cortical
dysplasias (FCD), excluding hippocampal sclerosis.
Results: Complete resection was achieved in 85 of 88 patients (96.6%), as proven by postoperative MRI 6
months after surgery. In contrast, the routine ﬁrst iopMR imaging before closure revealed radical
resection in only 66 of these 88 patients (75%). After re-intervention, the second iopMR imaging
demonstrated complete resection in 19 more patients. Thus, as a direct effect of iopMRI and
neuronavigation, overall resection rate was increased by 21.6%. An excellent seizure outcome Engel Class
I was found in 76.1% of patients during a mean follow-up of 26.4 months, irrespective of histological
entity (74% in CM, 75% in GG, 78% in DNT and 60% in FCD). No severe postoperative complications
occurred; permanent superior visual ﬁeld defects were detected in 10.2% and permanent dysphasia/
dyscalculia in 1.1%.
Conclusion: Reﬁned surgery using neuronavigation combined with iopMR imaging in LTLE surgery led to
radical resection in 96.6% of the patients, due to immediate correction of underestimated resection in
21.6% of patients. This protocol resulted in a favourable seizure outcome and a low complication rate.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
In lesional temporal lobe epilepsy excluding hippocampal
sclerosis, the extent of resection and the histology seem to be
the key prognostic factors for seizure outcome.1,2 Epilepsy
associated low grade tumours (gangliogliomas (GG) and
dysembryoplastic neuroepithelial tumours (DNT)), cavernoma-
tous malformations (CM) or focal cortical dysplasia (FCD) are the
main pathological entities in such cases.1,2 Intrinsic epilepsy
associated tumours may have diffuse borders and may be* Corresponding author at: Department of Neurosurgery, University Hospital
Erlangen, Schwabachanlage 6, 91054 Erlangen, Germany. Tel.: +49 9131 8544814;
fax: +49 9131 8534678.
E-mail address: karl.roessler@uk-erlangen.de (K. Roessler).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.11.013located adjacent to temporal speech areas, CM or FCD may have
contact to deep structures like speech or visual tracts.1 Thus,
intraoperative imaging and neuronavigation may enhance the
amount of surgical resection and avoid postoperative neurolog-
ical deterioration.4 We took account of this matter when our
operating theatre was equipped with an intraoperative 1.5 T
MRI suite in 2002. Additionally, in lesions near eloquent brain
tissue or tracts, functional MR imaging (fMRI) and diffusion
tensor imaging (DTI) may visualize eloquent cortex and ﬁbre
tracts preoperatively.3,5 These functional data can be integrated
into intraoperative navigational MR images to lower patient
numbers with residual tumour or neurological complications. To
our knowledge, this is the ﬁrst report on surgical and seizure
outcome results on a consecutive lesional temporal epilepsy
patient series by using neuronavigation together with iopMR
imaging during surgery.vier Ltd. All rights reserved.
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2.1. Preoperative examination protocol
Altogether, 88 patients (40 female, 48 male, mean age
37.2 yrs, from 12 to 69 yrs, 41 left sided) suffering from
medically refractory lesional temporal lobe epilepsy were
included in this retrospective investigation from a total series
of 345 consecutive patients with medical treatment refractory
epilepsy operated on in our department between August 2002
and March 2012. Type of seizures is shown in Table 1. Patients
with hippocampal sclerosis were excluded, because the surgical
procedure is standardized and anatomically deﬁned, without
needing neuronavigation or intraoperative MRI imaging. All
patients underwent an extensive presurgical epilepsy protocol
that consisted of video-EEG monitoring, high-resolution 1.5 and
3 Tesla (T) MRI scanning and neuropsychological testing
preoperatively, as well as at the postoperative follow-up
examinations in 6 month intervals. The pre-, intra- and
postoperative radiological protocol included all standard MRI
sequences for epilepsy diagnostics (T1-MPRAGE, FLAIR, T2, DTI
and inversion recovery images in multiple planes and standard
and temporal lobe corrected scanning positions) as well as T2*
gradient echo sequences for detecting the extent of hemosi-
derosis in the cavernoma cases. The results of these investiga-
tions were discussed in an interdisciplinary conference and a
surgical treatment plan was established. Preoperatively, 20
patients (22.2%) had fMRI imaging or DTI imaging for speech,
motor, sensory cortical areas and tracts because of the close
vicinity of the lesion to these functionally eloquent areas
(Table 1).Table 1
Patient demographics.
Number 88
Age Mean 37.2 
Male 
Female 
Type of seizures
Complex partial 65/88 
Generalized tonic-clonic 51/88 
Simple partial 46/88 
Absence 2/88 
Epilepsy duration 
Site of resection Right 
Left 
Surgery using IopMR imaging and neuronavigation Resection rate at
Resection rate co
Functional imaging used 
Histology Ganglioglioma 
Cavernoma 
DNET 
FCD 
Others 
Seizure outcome (N = 88) Engel IA 
IB 
IC 
2A 
2B 
2D 
3A 
4A 
4B 
4C 
Follow-up 2.2. BOLD and DTI imaging
We used 1.5 T MR clinical whole-body scanner with echo planar
imaging (Magnetom Sonata, Siemens Medical Solutions, Erlangen,
Germany, Fig. 2) equipped with a standard head coil for functional
imaging as previously described.4 The applied scan sequences
included a T1-weighted 3 D dataset (magnetization prepared rapid
acquisition gradient echo (MPRAGE) sequence; echo time (TE) of
4.38 ms, repetition time (TR) of 2090 ms, matrix size of 256  256,
ﬁeld of view (FOV) of 256 mm, slice thickness of 1 mm). The
applied activation protocols and stimulation paradigms to localize
Broca and Wernicke cortical speech areas as well as verbal memory
areas were described in detail elsewhere.4,6
Diffusion-tensor imaging (DTI) uses the directional properties
of diffusion of water molecules in brain tissue. The direction of
greatest diffusion measured with this technique matches the
dominant orientation of axons in white matter, thus displaying
neuronal ﬁbre tracts. The DTI data were acquired using a single-
shot spin-echo diffusion-weighted echo planar imaging (EPI)
sequence (TE 86 ms, TR 9200 ms, matrix size 128  128, FOV
198 mm, slice thickness 1.9 mm). The process of localizing ﬁbre
bundles was described previously.7,8 Diffusion-tensor information
was calculated and visualized, reconstructing ﬁbre tracts with the
‘‘ﬁbre tracking’’ module of the navigation planning software iPlan
2.6 (BrainLab, Feldkirchen, Germany). The diffusion tensors’ main
axis of direction had a minimum ﬁbre length of 50 mm. The
diffusion probability density function was used to determine
diffusion tensors and their preferred direction within a speciﬁc 3D-
brain position (voxel). The proportion of molecules in a voxel was
calculated by vector from six different diffusion weighted
acquisitions, each obtained with a different orientation of theFrom 12 to 69
N = 48
N = 40
73.9%
58%
52.3%
2.3%
Mean 9 yrs From 0.2 to 49
N = 47
N = 41
 time of iopMRI N = 66/88 75%
ntinuing surgery N = 85/88 96.6%
N = 20 22.2%
N = 36 40.9%
N = 23 26.1%
N = 9 10.2%
N = 10 11.4%
N = 10 11.4%
60 68.2%
6 6.8%
1 1.1%
3 3.4%
5 5.7%
1 1.1%
8 9.2%
1 1.1%
2 2.3%
1 1.1%
Mean 2 yrs From 0.2 to 7
K. Roessler et al. / Seizure 23 (2014) 201–207 203diffusion sensitizing gradients. We set the starting point (region of
interest, ROI) for pyramidal tract reconstruction in the primary
motor cortex (hand, arm, leg, foot area). Broca and Wernicke
cortical speech areas as well as the primary visual cortex were
chosen as a starting ROI for the language and visual tracts.
2.3. IopMR imaging and neuronavigation
First intraoperative MRI was performed, when the surgeon had
the impression of having resected the lesion completely and
planned to close the craniotomy, a second intraoperative MRI was
performed after the surgery was continued and a residual tumour
resected. Nimsky and colleagues already gave a detailed descrip-
tion of the intraoperative work-ﬂow in our iopMRI suite (1.5 T
iopMRI, Magnetom Sonata Maestro Class, Siemens Healthcare,
Erlangen, Germany, Fig. 2).9 The ﬁrst intraoperative MRI scans
included a T1-weighted MPRAGE sequence (TE 4.38 ms, TR
2020 ms, matrix size of 128  128 (interpolated to 256  256),
FOV 250 mm, slice thickness 1 mm, slab 16 cm), T2-weighted
coronal and transversal images (TE 98 ms, TR 6520 ms, matrix size
512  307, FOV 250 mm, slice thickness 3 mm) and DTI sequences
(TE 86 ms, TR 9200 ms, matrix size 128  128, FOV 240 mm, slice
thickness 3 mm). The same scanning protocol was used for both
pre- and intraoperative MRI. While the patient was shifted back
into the operating position, pre-operative functional data and
intraoperative MRI data were fused. The lesions were segmented
manually using our neuronavigation software (iPlan 2.6, Brainlab
AG, Feldkirchen, Germany). After registration of functional data
and current iopMRI data, these were transferred to an OPMI
Pentero operation microscope (Zeiss, Oberkochen, Germany, Figs. 1
and 2). The co-registration of in vivo MRI with anatomical
structures was accomplished with a mean error of 1.4  0.6 mm
when surgery was started. The local ethical committee of theFig. 1. Patient 63: A 22 yrs old male, presenting with medically refractory temporal lob
T2-weighted axial (A), coronal (B) MRI scans as well as in the T1-weighted saggital MPRAG
neuronavigation plan and projection of the lesion on to the skin (D) before beginning o
volume (green lines) onto the skin of the left temporal region, just in front of the externa
question mark temporal skin incision. (For interpretation of the references to colour inUniversity Erlangen-Nuremberg approved the use of intraoperative
MRI, and signed informed consent was provided by all patients.
2.4. Intraoperative electrocorticography (ECoG) and quantiﬁcation of
total resection
For determination of the epileptogenic zone (EZ) in patients
where the preoperative electro-clinical ﬁndings revealed a larger
epileptogenic zone than the extension of the lesion, additional
intraoperative ECoG was performed in 16 patients (15.7%) after
exposure of the lesion and the perilesional brain area. Cortical
electrode strips, grids or depth electrodes were placed to deﬁne
epileptogenic areas. We used either a combination of up to four 4- or
6-contact subdural strips, 4-contact depth electrodes for hippocam-
pal and amygdala positioning, 32-electrode subdural grids (compa-
nies: Ad-Tech Medical Instrument Corporation, Racine, WI, U.S.A.,
and PMT/Permark Corporation, Chanhassen, MN, U.S.A.) as well as
an electrode rack consisting of 16 surface electrodes. Anatomical
position of the electrodes in relation to the lesion and the
perilesional tissue was determined by iopMRI scans in all 16
patients; a distinct resection area was deﬁned from ECoG
measurements and segmented as the resection volume for the
neuronavigation assisted resection. We deﬁned ‘‘total resection’’ as
the complete removal of the predetermined ECoG deﬁned tailored
resection volume (that is, preoperatively deﬁned lesion contours or
ECoG deﬁned ‘‘tailored’’ extent) and measured the extent of
resection by comparing pre- and intraoperative MR images after
fusion using the neuronavigation work station.
2.5. Surgical technique
Depending on the localization of the temporal lesion, we
performed either a standard temporal or modiﬁed fronto-temporale seizures, showing a left temporal lesion with peri-lesional hypointense signal in
E sequence (C) (postoperative histology: ganglioglioma WHO Grade I). Preoperative
f surgery: The photograph demonstrates the projection of the segmented tumour
l auditory canal (left side), zygoma on the top. Black line represents the base of the
 this ﬁgure legend, the reader is referred to the web version of the article.)
Fig. 2. MRI suite and operating theatre: The operation position of the head is outside the 5 Gauss line, therefore, normal ferromagnetic instruments can be used (B). For
intraoperative scanning, the open head is draped and the table rotated into the scanning position and moved into the scanner (A). Residual lesion identiﬁed during iopMR
imaging and re-segmented residual lesion of patient No. 63 (C) and the projection of the lesion on to the operating ﬁeld for navigated resection (D) after rotating back the
patient into the operating position.
K. Roessler et al. / Seizure 23 (2014) 201–207204craniotomy. Microsurgical techniques were used for lesionec-
tomies or tailored resections according to intraoperative neuro-
navigation, where we kept close to the displayed boundaries of
suspected pathological tissue or ECoG deﬁned extended lesionFig. 3. Comparison of 1st (A, C) and 2nd (B, D) iopMR imaging visualizing the residual gan
arrows.volumes and spared normal brain (Fig. 2). After we had the
impression of complete resection, an iopMRI scan was performed.
If MR images showed remnant pathological tissue or incomplete
resection of the designated EZ, we updated neuronavigation withglioglioma and demonstrating the successful resection of the residual tumour (B, D)
Fig. 4. First intraoperative MRI scan in 88 patients revealed 75% complete resections. In 25%, residual lesions were detected after the surgeon had decided to close the
craniotomy, due to the underestimated resection volume of the leading surgeon. After re-segmentation and targeted resection of the residuals, altogether 96.6% of the lesions
in 88 patients were resected completely. Due to intraoperative MR imaging, the radical resection rate was increased by 21.6% in this patient cohort. This led to an Engel Class 1
seizure outcome in 76.1% of the patients, compared to 58% in 66 complete resections before intraoperative MRI scanning, if the surgeon would not have employed
intraoperative MR imaging for resection control.
Fig. 5. Engel classiﬁcation outcome numbers of the total study population of 88
patients.
K. Roessler et al. / Seizure 23 (2014) 201–207 205intraoperative MR imaging data and continued surgery (Fig. 2).
A ﬁnal MRI scan then conﬁrmed maximum extent of resection
before the closing procedure (Fig. 3).
2.6. Deﬁnition of postoperative neurological deterioration and
epilepsy outcome
Neurological outcome was documented at three points in time:
(1) immediately after surgery when the patient was discharged
from hospital, (2) three months after surgery in our outpatient
centre, and (3) at the most recent follow-up visit. We deﬁned
manifest hemiparesis, complete hemianopia, aphasia or memory
disturbance as severe neurological deﬁcits. Upper visual ﬁeld
deﬁcits, slight aphasia or latent mono-paresis were termed mild
neurological deﬁcits.
The most recent Engel classiﬁcation10 was applied to evaluate
post-surgery seizure outcome. An excellent seizure outcome was
deﬁned as Engel Class IA, whereas a favourable seizure outcome
included Engel’s Grades I and II. The categories III and IV were
assigned to the category poor seizure outcome.
Patients’ most recent neurological and epilepsy outcome data
were gained from the follow-up examinations in the Neurological
Epilepsy Centre at the University Hospital Erlangen and via
telephone interviews.
3. Results
The most common histological diagnoses of temporal lesions in
the investigated patients were: 40.9% GG (n = 36), 26.1% CM
(n = 23), 10.2% DNTs (n = 9) and 11.4% FCDs (n = 10) (Table 1). At
the end of surgery, complete resection of the lesion or ECoG
deﬁned extended lesion was achieved in 85 of 88 patients (96.6%)
operated on using iopMRI. During surgery, ﬁrst iopMRI before
closure revealed total resection of the target volume in only 66 of
88 patients (75%), further resection led to a removal of remnant
pathological tissue in 19 (21.6%) more patients (Fig. 4). Thus, as adirect effect of intraoperative MR imaging, overall resection rate
was improved by 21.6%. Altogether, in 76.1% of re-evaluated
patients (67/88) an Engel Class I seizure outcome was found during
a mean follow-up of 26.4 months (60/88 = 68.2% Engel Class IA),
Fig. 5. Highest percentage of excellent seizure control was found in
DNT resections (78% Engel Class I), in GG resections (75% Engel
Class I), and in CM resections (74% Engel Class I). In the FCD group,
the Engel Class IA outcome was 60%. Within 51 tumour patients,
MRI follow-up was available in 88.9%. From 3 incompletely
resected tumours, 2 had stable disease and 1 tumour progression.
In 7.8% (4 patients) new tumours were detected during follow-up,
all currently stable in size (26.4 months mean FU). Postoperative
surgical revision was necessary in none of the patients and medical
complications occurred in 4.6% (4/88). Neurological complications
occurred transiently (trigeminal hypaesthesia 1.1%, double vision
1.1%,) or permanently: mild dysphasia/dyscalculia in 1.1%,
contralateral superior visual ﬁeld defects 10.2%, with no severe
neurological deterioration.
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4.1. Summary of ﬁndings
In our retrospective study of 88 lesional temporal lobe epilepsy
patients excluding hippocampal sclerosis who underwent surgery
with the aid of neuronavigation combined with intraoperative MR
imaging for intraoperative resection control, we demonstrated an
intraoperative improvement of the overall resection rate of 21.6%,
independent of the resected pathology. This led to an excellent
Engel Class I seizure outcome of 76.1%, with an average of 68.2%
complete seizure free patients (Engel Class IA) and no severe
permanent neurological complications.
4.2. MR tomographical resection control and intraoperative
neuronavigation
We have established 1.5 T intraoperative MR imaging, mainly
for glioma and pituitary surgery nearly a decade ago.11 Back then,
further resection after a ﬁrst intraoperative MR imaging before
closing was performed in 39% of patients to achieve complete
resection within 200 investigated patients. Other authors using
iopMRI for resection control reported similar ﬁndings when
performing an intraoperative image update. Here, further resection
of remnant lesions according to intraoperative MR images were
performed in up to 49% of the cases.12–14
In lesional epilepsy surgery of the temporal lobe excluding
hippocampal sclerosis, 4 distinct lesions present as an epileptic
focus most frequently: cavernomatous malformations (CM),
gangliogliomas (GG), dysembryoplastic neuroepithelial tumours
(DNT) and focal cortical dysplasias (FCD),2 Table 1. DNTs and GGs
as well as FCDs in most cases have diffuse borders, which are
hardly distinguishable from normal brain during surgery. Thus,
radical resection rates in GG rarely reach 75%, with consecutive low
rates of seizure freedom of only 54% after subtotal resection.15
Additionally, for surgery of FCDs, the complete resection seems the
only signiﬁcant parameter for seizure freedom after surgery in
large series reviewed.16 Moreover, in CM, radical resection of the
lesion as well as the hemosiderotic rim seems to be a key
prognostic factor for epilepsy control, best achievable by using
intraoperative resection control.17
Therefore, we started to operate on patients with temporal lobe
epilepsy due to such lesions using a 1.5 T intraoperative MR unit
August 2002. Additionally, implementation of intraoperative
neuronavigation, functional imaging4,5 and ECoG in cases with
suggested extended epileptogenic zone was performed.
Within our consecutive series of 88 patients, the highest portion
of surgically treated lesions consists of GGs (40.9%), followed by
CMs (26.1%), FCDs (11.4%) and DNTs (10.2%), Table 1. Altogether,
we achieved an exceptionally high percentage of complete
resections in 96.6% of patients (85/88) due to our surgical protocol,
where an intraoperative MR imaging had to be performed
immediately before closing when the leading surgeon was sure
of having achieved a radical resection of the lesion or the
intraoperative ECoG predeﬁned extended resection volume,
Figs. 2–5. Notably, due to that protocol, the resection rate at this
stage of surgery was found to be only 75% (66/88) in an iopMR
imaging at this time before closing, Table 1. Similar ﬁndings had
been already described in an era before iopMRI, clearly demon-
strating that even in temporo-mesial resection, experienced
neurosurgeons tend to underestimate their rate of resection after
surgery, but without the possibility to correct this unsatisfying
result when demonstrated in late postoperative scans.18 As a
consequence of this iopMRI imaging, we identiﬁed 22 residual
lesions intraoperatively and used the updated neuronavigation
data for segmentation and projection of remnant tissue into theoperating ﬁeld again, further continuing surgery, Figs. 2 and 3.
Thereafter, ﬁnal MRI scans documented 100% resection in all 85
patients (96.6%), Table 1; however, second iopMRI scans showed
remnant tumour masses in 3 more patients, not amenable to
surgery due to eloquent location. Nevertheless, iopMRI had led to
an increase of the primary resection rate of 21.6%. Compared to our
previous results in glioma and pituitary patients11 this seems low,
but in lesional epilepsy surgery, this percentage could directly be
translated into an equal percentage of seizure-free patients. With a
total resection rate of 96.6% in the iopMRI group, this is exceptional
high. No comparable reports dealing with this topic in lesional
temporal lobe epilepsy surgery exist in the literature.
4.3. Residual and recurrent tumours and reoperations
Altogether, this lesional temporal lobe patient series included
51 tumour patients (58%), Table 1. Most common histopathology
reports of the tumour patients within the series were in 70.6%
gangliogliomas (n = 36) and in 10.2% DNTs (n = 9). Within these
patients, MRI follow-up was available in 88.9%. The 3% incom-
pletely resected tumours were all gangliogliomas, 2 had stable
disease and 1 had tumour progression during FU of 26.4 months. In
7.8%, new tumours (3 gangliogliomas, 1 DNT) were detected during
mean FU, all of them currently being stable in growth. Three of 36
gangliogliomas (8.3%) developed recurrences, despite WHO I
histology. Compared to the literature, where 2–10% recurrences
are reported for Grade I GG, this reﬂects exactly our ﬁndings.19,20
4.4. Neurological, seizure and lesional outcome
No severe transient or permanent neurological complications
such as hemiparesis occurred. One permanent dysphasia/dyscal-
culia was documented (1.1%), one patient with transient trigemi-
nal hypaesthesia and one patient with transient double vision were
detected. The percentage of permanent upper visual ﬁeld defects
was 10.2%. All neurological complications were exactly within the
reported expectable range and particularly postoperative infec-
tions did not occur.21,22 This underlines the fact, that the described
algorithm using intraoperative MR imaging does not add any
additional risks or complications to the surgical procedure.
Concerning seizure outcome, we found an Engel Class I seizure
outcome in 76.1% of our patients, Fig. 5. This did not differ very
much within the four main pathological subgroups. The far best
result was found in the investigated tumour and cavernoma
population, with Engel Class I outcome rates of 74% in CM, 75% in
GG, 78% in DNT. A slightly reduced percentage of Engel Class I
outcome was found in the FCD group with 60% during a mean
follow-up of 26.4 months. This conﬁrms the results of the
literature, were patients following CM resection have best seizure
outcomes and up to 89% seizure freedom rates, as compared to
FCDs, which have a reduced chance of seizure freedom rates of only
43–67% due to the diffuse and often MRI-negative appearance of
such lesions.2,23 For that reason, we found the highest ECoG
tailored resection rate (77.8%) in FCD surgery. However, favourable
seizure outcome in cavernomas and gangliogliomas may also
reﬂect the highest resection amount as well as the highest
intraoperative re-resection rates due to iopMRI detection of
intraoperative residuals in these two categories.
4.5. Limitations and strength of the study
Important limitations of our study are the lack of prospective,
randomized controlled data that compare surgery of epileptogenic
temporal lesions with and without using neuronavigation in
combination with intraoperative MRI. Additionally to the lack of
randomization, the availability of intraoperative MR imaging at the
K. Roessler et al. / Seizure 23 (2014) 201–207 207study site might have led to a bias of using highly sophisticated
technology in epilepsy surgery to justify the investment costs of
the equipment. As an alternative, further improvement concerning
the identiﬁcation of eloquent brain areas and possible post-
surgical deﬁcits could have been performed using awake
craniotomies and intraoperative electrophysiological and neuro-
logical monitoring. Nevertheless, we have proved the validity of
our multimodal neuronavigation approach and integration of
functional MRI and DTI imaging within conventional surgery in
many published studies during the last decade.8,9,11 Another
problem concerning the use of preoperative functional data during
surgery is volumetric brain deformation and intraoperative loss of
cerebrospinal ﬂuid (‘‘brain shift’’), which is known to diminish the
accuracy of the depicted eloquent brain areas and ﬁbre tracts.24 In
our study, we took account for the brain structure translocation
and performed intraoperative MRI updates with new acquisition of
navigation data and reassignment of residual pathological tissue
using the navigation planning software. In all of those patients,
remnant tissue could be removed completely, if it was not located
within functional areas.
5. Conclusion
This retrospective study on surgically treated epilepsy patients
with reﬁnements in surgical technique demonstrated a possibly
favourable value of neuronavigation in combination with intra-
operative MRI during resection of epilepsy associated temporal
lesions. In 21.6% of iopMR imaging conducted surgeries, an
incomplete resection of the underlying lesion was found at the
time when the surgeon had decided to close the craniotomy, due to
an underestimation of resected lesion volume. Thus, the decision
to continue surgery according to intraoperative MRI with re-
segmented data of residual lesions enhanced the total resection
rate from 75% up to 96.6%. This multimodal pre- and intraoperative
imaging approach led to a favourable mean Engel Class I outcome
in 76.1% of the patients with a general low morbidity rate in a
considerable high number of patients.
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